BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Papaverine

An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.

299+ PubMed studies analyzed · 13 RCTs · Evidence Score: 47.1

Research Domains

Papaverine has been studied across 18 research domains including ❤️ Cardiovascular, ♀♂ Sexual Health, 🦴 Bone & Joint, 🧠 Focus & Attention, 🔬 Inflammation. The primary research focus is ❤️ Cardiovascular with 11% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Papaverine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sildenafil
9 shared targets
Melphalan
16 shared targets
Cilostazol
12 shared targets
vinpocetine
12 shared targets
Flutamide
15 shared targets
17
13 shared targets
Clofarabine
11 shared targets
Nisoldipine
20 shared targets
Mometasone
14 shared targets
deguelin
10 shared targets
Loading evidence profile...

This evidence profile for Papaverine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.